BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25211179)

  • 1. Routine magnetic resonance imaging for idiopathic olfactory loss: a modeling-based economic evaluation.
    Rudmik L; Smith KA; Soler ZM; Schlosser RJ; Smith TL
    JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):911-7. PubMed ID: 25211179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis.
    Rudmik L; Leung R
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):802-8. PubMed ID: 25123233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss.
    Hoekman PK; Houlton JJ; Seiden AM
    Laryngoscope; 2014 Feb; 124(2):365-8. PubMed ID: 23775878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
    de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
    Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of the endoscopic versus microscopic approach for pituitary adenoma resection.
    Rudmik L; Starreveld YP; Vandergrift WA; Banglawala SM; Soler ZM
    Laryngoscope; 2015 Jan; 125(1):16-24. PubMed ID: 24938934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-tiered approach to MRI for hearing loss: incremental cost of a comprehensive MRI over high-resolution T2-weighted imaging.
    Sharma A; Viets R; Parsons MS; Reis M; Chrisinger J; Wippold FJ
    AJR Am J Roentgenol; 2014 Jan; 202(1):136-44. PubMed ID: 24370138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic polypectomy in the clinic: a pilot cost-effectiveness analysis.
    Rudmik L; Smith KA; Kilty S
    Clin Otolaryngol; 2016 Apr; 41(2):110-7. PubMed ID: 26053107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To image or not to image? A cost-effectiveness analysis of MRI for patients with asymmetric sensorineural hearing loss.
    Hojjat H; Svider PF; Davoodian P; Hong RS; Folbe AJ; Eloy JA; A Shkoukani M
    Laryngoscope; 2017 Apr; 127(4):939-944. PubMed ID: 27686371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of routine computed tomography in the evaluation of idiopathic unilateral vocal fold paralysis.
    Hojjat H; Svider PF; Folbe AJ; Raza SN; Carron MA; Shkoukani MA; Merati AL; Mayerhoff RM
    Laryngoscope; 2017 Feb; 127(2):440-444. PubMed ID: 27601300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cost-effectiveness Analysis of Early vs Late Tracheostomy.
    Liu CC; Rudmik L
    JAMA Otolaryngol Head Neck Surg; 2016 Oct; 142(10):981-987. PubMed ID: 27468115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Diagnostic Strategies for Suspected Scaphoid Fractures.
    Yin ZG; Zhang JB; Gong KT
    J Orthop Trauma; 2015 Aug; 29(8):e245-52. PubMed ID: 25756914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of magnetic resonance imaging in the workup of the dysosmia patient.
    Decker JR; Meen EK; Kern RC; Chandra RK
    Int Forum Allergy Rhinol; 2013 Jan; 3(1):56-61. PubMed ID: 22786891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of magnetic resonance imaging versus ultrasound for the detection of symptomatic full-thickness supraspinatus tendon tears.
    Gyftopoulos S; Guja KE; Subhas N; Virk MS; Gold HT
    J Shoulder Elbow Surg; 2017 Dec; 26(12):2067-2077. PubMed ID: 28893546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the diagnosis of meniscus tears.
    Mather RC; Garrett WE; Cole BJ; Hussey K; Bolognesi MP; Lassiter T; Orlando LA
    Am J Sports Med; 2015 Jan; 43(1):128-37. PubMed ID: 25451791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health-economic evaluation of magnetic resonance imaging before biopsy for diagnosis of prostate cancer].
    Stadlbauer A; Bernt R; Salomonowitz E; Plas E; Strunk G; Eberhardt K
    Rofo; 2011 Oct; 183(10):925-32. PubMed ID: 21863536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
    Lu L; Peters J; Roome C; Stein K
    BJU Int; 2012 Apr; 109(8):1183-92. PubMed ID: 21883830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of test phase implantation strategies for InterStim® sacral neuromodulation.
    Kantartzis KL; Shepherd JP
    Female Pelvic Med Reconstr Surg; 2013; 19(6):322-7. PubMed ID: 24165444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis.
    Remer EM; Obuchowski N; Ellis JD; Rice TW; Adelstein DJ; Baker ME
    AJR Am J Roentgenol; 2000 Apr; 174(4):1033-9. PubMed ID: 10749246
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.